Page 24 - Priya Singhal News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Livforsakringsbolaget Skandia Omsesidigt Raises Position in Biogen Inc (NASDAQ:BIIB)

Livforsakringsbolaget Skandia Omsesidigt Raises Position in Biogen Inc (NASDAQ:BIIB)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesPriya singhalLivforsakringsbolaget skandia omsesidigtErick rowinskyAmerica bofaNeedham companyCapital managementWells fargo companyBiogen incEverence capital management incVontobel holding ltdBiogen company profileMackenzie financial corpSecurities exchange commissionFree reportSkandia omsesidigt

Livforsakringsbolaget Skandia Omsesidigt Has $111,000 Position in Biogen Inc (NASDAQ:BIIB)

Livforsakringsbolaget Skandia Omsesidigt Has $111,000 Position in Biogen Inc (NASDAQ:BIIB)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesPiper sandlerErick rowinskyLivforsakringsbolaget skandia omsesidigtAmerica bofaPriya singhalKb financial partnersNeedham companyExchange commissionBiogen incCanaccord genuity groupAltshuler shaham ltdSecurities exchange commissionFamily officeFree reportSkandia omsesidigt

Biogen (NASDAQ:BIIB) PT Lowered to $214 00

Biogen (NASDAQ:BIIB – Get Free Report) had its price objective cut by research analysts at UBS Group from $250.00 to $214.00 in a research report issued on Wednesday, Benzinga reports. The firm presently has a “neutral” rating on the biotechnology company’s stock. UBS Group’s price objective indicates a potential upside of 11.37% from the stock’s […]

United statesWilliam blairErick rowinskyPriya singhalPiper sandlerRise advisorsBiogen company profileBiogen incAltshuler shaham ltdJpmorgan chase coGet free reportStock downDirector ericShaham ltdAsset managementFinancial advisory

UBS Group Lowers Biogen (NASDAQ:BIIB) Price Target to $214 00

Biogen (NASDAQ:BIIB – Get Free Report) had its price objective reduced by analysts at UBS Group from $250.00 to $214.00 in a note issued to investors on Wednesday, Benzinga reports. The brokerage presently has a “neutral” rating on the biotechnology company’s stock. UBS Group’s price objective points to a potential upside of 11.37% from the […]

United statesPriya singhalErick rowinskySecurities exchange commissionCanaccord genuity groupFirst trust advisorsPricet rowe associates incBiogen company profileBiogen incNorges bankVanguard group incGet free reportGenuity groupExchange commissionDirector ericTrust advisors

Biogen Inc (NASDAQ:BIIB) Holdings Decreased by Flputnam Investment Management Co

Flputnam Investment Management Co. reduced its stake in shares of Biogen Inc. (NASDAQ:BIIB – Free Report) by 8.7% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,931 shares of the biotechnology company’s stock after selling 185 shares during the […]

United statesPriya singhalErick rowinskyBiogen incAltshuler shaham ltdFamily officeKb financial partnersExchange commissionRoyal bankCantor fitzgeraldFlputnam investment management coSecurities exchange commissionFlputnam investment managementFree reportInvestment managementShaham ltd